title: New anticoagulant agents in acute coronary syndromes.
authors.affiliation: 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria.
authors.forename: Thomas
authors.initials: T
authors.lastname: Höchtl
authors.forename: Serdar
authors.initials: S
authors.lastname: Farhan
authors.forename: Johann
authors.initials: J
authors.lastname: Wojta
authors.forename: Kurt
authors.initials: K
authors.lastname: Huber
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D000077425:Fondaparinux; D006629:Hirudins; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D010446:Peptide Fragments / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D003497:Cyclic N-Oxides; D006629:Hirudins; D009025:Morpholines; D010446:Peptide Fragments; D011134:Polysaccharides; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D011994:Recombinant Proteins; D013876:Thiophenes; C522181:apixaban; D000069552:Rivaroxaban; D000077425:Fondaparinux; C435830:otamixaban; C074619:bivalirudin